-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
5-Nitrobarbituric acid hydrate
Category | Herpes simplex Virus (HSV) |
CAS | 209529-81-7 |
Description | 5-Nitrobarbituric acid is a herpes simplex virus type-1 (HSV-1) inhibitor (IC50=1.7 μM). |
Product Information
Synonyms | 5-nitro-1,3-diazinane-2,4,6-trione;hydrate |
IUPAC Name | 5-nitro-1,3-diazinane-2,4,6-trione;hydrate |
Molecular Weight | 173.08 (anhydrous basis) |
Molecular Formula | C4H3N3O5 · xH2O |
Canonical SMILES | C1(C(=O)NC(=O)NC1=O)[N+](=O)[O-].O |
InChI | InChI=1S/C4H3N3O5.H2O/c8-2-1(7(11)12)3(9)6-4(10)5-2;/h1H,(H2,5,6,8,9,10);1H2 |
InChIKey | YKGZAIJTCJOZNK-UHFFFAOYSA-N |
Boiling Point | 303.69°C |
Melting Point | 180.5°C |
Purity | 95% |
Density | 1.8±0.1 g/cm3 |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Solid powder |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 259 |
Exact Mass | 173.007263 |
Index Of Refraction | 1.581 |
In Vitro | 5-Nitrobarbituric acid can inhibit vero cell growth. Cell Cytotoxicity Assay Cell Line: Vero cells Concentration: 0.06-5 μM Incubation Time: 2 hours Result: Showed high cytotoxicity to vero cells. |
PSA | 121.09000 |
Target | HSV |
XLogP3-AA | -1.1 |